BARDA enlisting start-ups in fight against COVID-19 via JLABS collaboration
JLABS funneling start-up innovation to BARDA via Blue Knight initiative
JLABS is providing BARDA access to start-up innovation the government agency can fast track to fight COVID-19 and future health threats.
A collaboration between JLABS and BARDA gives the government agency access to start-ups that it needs to fast track new, innovative COVID-19 therapies and diagnostics it otherwise would struggle to find.
The Johnson & Johnson (NYSE:JNJ) incubator and the Biomedical Advanced Research and Development Authority (BARDA) launched the Blue Knight collaboration in April